Company facts
- Headquarters
- San Carlos, California
- Most recent report
- 8-K, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 47 filings
- On EDGAR
- CIK 2058707
- Fiscal year ends
- December
- Filer status
- Emerging growth company
News 1
Prospectuses and Registrations 5
Ownership 8 of 35
- 4 Insider reported a trade Aug 13, 2026
- 4 Insider reported a trade Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 12, 2026
- SCHEDULE 13D Large holder reported an active stake Aug 11, 2026
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Aug 10, 2026
- 4 Insider reported a trade Aug 7, 2026
- 4 Insider reported a trade Aug 7, 2026
Other 6
- EFFECT Notice that a registration became effective Aug 4, 2026
- CERT Exchange certified a listing Aug 4, 2026
- 8-A12B Registration of a security for exchange listing Jul 29, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jun 5, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Feb 12, 2026
- DRS Draft registration statement, submitted confidentially Dec 19, 2025
Everything here comes from Attovia Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.